Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

French hospitals team up to solve deadly graft infection mystery

NCT ID NCT07143409

First seen Dec 24, 2025 · Last updated Jun 23, 2026 · Updated 30 times

Summary

This study reviews 300 cases of fungal infections in vascular grafts from 12 French hospitals over 10 years. Researchers aim to understand how these infections are treated and what affects patient survival. The goal is to find patterns that could improve care for this rare but life-threatening condition.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FUNGAL INFECTION are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • CHU Bordeaux

    Bordeaux, France

    Contact Phone: •••-•••-•••• Email: •••••@•••••

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to

If successful, this study could identify better treatment strategies for rare but deadly fungal infections in vascular grafts.

What could go wrong

This is an observational study, not a clinical trial testing a new treatment. It cannot prove what works best, only describe past cases.

Conditions

The condition(s) this trial relates to.

fungal infectious disease Torulopsis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.